Home › Calculator › DYN Dividend Calculator 2026
DYN Dividend DRIP Calculator 2026
8.18% YieldHealthcareDyne Therapeutics, Inc. · NASDAQ
Price: $24.44 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When DYN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your DYN snowball 📈
$10,000 in DYN → $22.0K in 10 years · $138.42/month
About Dyne Therapeutics, Inc. (DYN) — Dividend Analysis 2026
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
Compare DYN with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full DYN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open DYN position with:
🌍 DYN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold DYN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 8.18% | 5.38% | $818 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 6.95% | 4.15% | $695 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 6.54% | 3.74% | $654 / yr |
| 🇬🇧 UK ISA | 0% | 8.18% | 5.38% | $818 / yr |
| 🇬🇧 UK Taxable | 8.75% | 7.46% | 4.66% | $746 / yr |
| 🇨🇦 TFSA | 0% | 8.18% | 5.38% | $818 / yr |
| 🇨🇦 CA Taxable | 25% | 6.13% | 3.33% | $614 / yr |
| 🇦🇺 Super (pension) | 15% | 6.95% | 4.15% | $695 / yr |
| 🇦🇺 AU Taxable | 30% | 5.73% | 2.93% | $573 / yr |
| 🇩🇪 DE Taxable | 26.375% | 6.02% | 3.22% | $602 / yr |
| 🇫🇷 FR Taxable | 30% | 5.73% | 2.93% | $573 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 DYN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 DYN Dividend Payment Schedule
DYN pays quarterly — 4 times per year. Next ex-div: TBD.
📊 DYN vs Healthcare Benchmarks
How DYN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for DYN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ DYN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-07-06 | 253,039 | $22.79 | $5.77M | ||
| Sale | 2026-07-07 | 124,379 | $23.17 | $2.88M | ||
| Sale | 2026-07-07 | 29,587 | $23.62 | $698.8K | ||
| Sale | 2026-07-06 | 127,182 | $22.79 | $2.90M | ||
| Sale | 2026-07-07 | 62,543 | $23.17 | $1.45M | ||
| Sale | 2026-07-07 | 14,844 | $23.62 | $350.6K | ||
| Sale | 2026-07-06 | 100,019 | $22.79 | $2.28M | ||
| Sale | 2026-07-07 | 49,193 | $23.17 | $1.14M | ||
| Sale | 2026-07-07 | 11,665 | $23.62 | $275.5K | ||
| Sale | 2026-07-07 | 5,000 | $23.61 | $118.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the DYN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Dyne Therapeutics, Inc. (DYN) is currently trading at $24.44, 42% below its 52-week high. The current dividend yield is 8.18% based on an annual payout of $2.00 per share.
DYN (Dyne Therapeutics, Inc.) — 8.18% Dividend Yield Analysis
Dyne Therapeutics, Inc. (DYN) is a healthcare stock currently trading at $24.44 with a dividend yield of 8.18%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (8.18%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.